BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of $28.75 billion. The enterprise value is $27.21 billion.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BeiGene has 107.54 million shares outstanding. The number of shares has increased by 0.86% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 107.54M |
| Shares Change (YoY) | +0.86% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | 4.61% |
| Owned by Institutions (%) | 48.79% |
| Float | 74.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 184.94 |
| PS Ratio | 7.39 |
| Forward PS | 1.68 |
| PB Ratio | 8.56 |
| P/TBV Ratio | 8.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.80 |
| Quick Ratio | 1.51 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.61 |
Financial Efficiency
Return on equity (ROE) is -18.77% and return on invested capital (ROIC) is -8.01%.
| Return on Equity (ROE) | -18.77% |
| Return on Assets (ROA) | -6.07% |
| Return on Invested Capital (ROIC) | -8.01% |
| Return on Capital Employed (ROCE) | -15.35% |
| Revenue Per Employee | $346,386 |
| Profits Per Employee | -$58,617 |
| Employee Count | 11,000 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, BeiGene has paid $111.79 million in taxes.
| Income Tax | 111.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.42% in the last 52 weeks. The beta is 0.65, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +72.42% |
| 50-Day Moving Average | 241.85 |
| 200-Day Moving Average | 201.86 |
| Relative Strength Index (RSI) | 60.69 |
| Average Volume (20 Days) | 499,832 |
Short Selling Information
The latest short interest is 1.48 million, so 1.38% of the outstanding shares have been sold short.
| Short Interest | 1.48M |
| Short Previous Month | 1.41M |
| Short % of Shares Out | 1.38% |
| Short % of Float | 1.99% |
| Short Ratio (days to cover) | 2.54 |
Income Statement
In the last 12 months, BeiGene had revenue of $3.81 billion and -$644.79 million in losses. Loss per share was -$6.12.
| Revenue | 3.81B |
| Gross Profit | 3.22B |
| Operating Income | -569.01M |
| Pretax Income | n/a |
| Net Income | -644.79M |
| EBITDA | -401.98M |
| EBIT | -569.01M |
| Loss Per Share | -$6.12 |
Full Income StatementBalance Sheet
The company has $2.63 billion in cash and $1.08 billion in debt, giving a net cash position of $1.55 billion or $14.39 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 1.08B |
| Net Cash | 1.55B |
| Net Cash Per Share | $14.39 |
| Equity (Book Value) | 3.33B |
| Book Value Per Share | 31.22 |
| Working Capital | 1.78B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$140.63 million and capital expenditures -$492.66 million, giving a free cash flow of -$633.29 million.
| Operating Cash Flow | -140.63M |
| Capital Expenditures | -492.66M |
| Free Cash Flow | -633.29M |
| FCF Per Share | -$5.89 |
Full Cash Flow StatementMargins
Gross margin is 84.41%, with operating and profit margins of -14.93% and -16.92%.
| Gross Margin | 84.41% |
| Operating Margin | -14.93% |
| Pretax Margin | -13.99% |
| Profit Margin | -16.92% |
| EBITDA Margin | -10.55% |
| EBIT Margin | -14.93% |
| FCF Margin | n/a |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.86% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.24% |
| FCF Yield | -2.20% |
Analyst Forecast
The average price target for BeiGene is $330.50, which is 23.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $330.50 |
| Price Target Difference | 23.60% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 73.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 2.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.93 |
| Piotroski F-Score | 3 |